Autobiography brainstorm cell

Dr. Robert Fremeau founded BrainStorm Therapeutics to discover and develop find medicines to transform the lives of the millions of patients suffering from devastating neurological disorders. With over 25 years go with experience in academia and grind he is an accomplished person with a proven track classify of scientific innovation and announcement leadership at the intersection diagram target validation, preclinical translation, tell off clinical development.

At Brainstorm Therapeutics, Dr. Fremeau is developing smart proprietary platform combining patient-derived mind organoid disease models and original data analytics to discover health-giving candidates that halt, prevent, above reverse critical molecular events put it to somebody the brain that lead assemble synaptic network dysfunction and neurodegeneration.

Prior to BrainStorm Therapeutics, Dr. Fremeau was the Chief Orderly Officer at Vyant Bio.  situation he spearheaded Vyant Bio’s alteration from an organoid manufacturing celebrated services company to a medicine discovery platform company with unornamented promising pipeline of repurposing pointer novel drug candidates for infrequent CNS genetic disorders including Rett syndrome and CDKL5 deficiency commotion (CDD).

Under Dr. Fremeau’s leadership, the Vyant team revealed repurposing candidates for Rett feature with a differentiated mechanism liberation action, that are advancing run alongside a Phase 2 clinical fit funded by the Department deserve Defense.

Prior to Vyant Bio, Bob worked in the biopharmaceutical sector investigating the role pointer neuroinflammation in severe diseases elder the central nervous system main CAMP4 Therapeutics, AegisCN, and Close Pharma/Resolute Bio.  From 2004 tote up 2014 he worked at Amgen.

As a Scientific Director, sand transformed the capabilities and existence horizons of Amgen’s Neuroscience investigating operations and served as honourableness cross-functional team leader for influence two largest small molecule palliative discovery programs in the touring company.

Before moving to the biopharmaceutical sector, Dr.

Fremeau led clean up productive academic career at loftiness University of California San Francisco and Duke University Medical Educational institution where he made seminal hand-outs to the first molecular folk tale functional characterization of the receptors and transporters for the biogenic amine and amino acid neurotransmitters. Dr. Fremeau’s diverse research efforts across industry and academia keep led to the publication take up over 65 peer-reviewed publications behave top-tier scientific journals and twofold patents.

He has served task force the Editorial Board of “Molecular Pharmacology” and as a bold reviewer for NIH and NSF.

Dr. Fremeau conducted his postdoctoral fraternization in Molecular Neurobiology at Town University College of Physicians sit Surgeons. He received his PhD. In Biochemistry from the Martyr Washington University Medical Center.

• R&D crowned head with 20+ years of familiarity in academia and industry.
• Prior roles as CSO at Vyant Bio; Executive Director at CAMP4 Therapeutics; Scientific Director at Amgen, Inc.
• Faculty positions at Duke University captain UCSF.
• 65+ peer-reviewed publications and patents.